Intercept Pharmaceuticals Inc (ICPT) President & CEO Mark Pruzanski Sold $5.1 million of Shares

- By insider

President & CEO of Intercept Pharmaceuticals Inc (ICPT) Mark Pruzanski sold 50,000 shares of ICPT on 11/16/2018 at an average price of $101.07 a share. The total sale was $5.1 million.

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need. Intercept Pharmaceuticals Inc has a market cap of $3.05 billion; its shares were traded at around $102.70 with and P/S ratio of 17.11.

• Warning! GuruFocus has detected 3 Warning Signs with ICPT. Click here to check it out.

• ICPT 15-Year Financial Data

• The intrinsic value of ICPT

• Peter Lynch Chart of ICPT

CEO Recent Trades:

• President & CEO Mark Pruzanski sold 50,000 shares of ICPT stock on 11/16/2018 at the average price of $101.07. The price of the stock has increased by 1.61% since.

Directors and Officers Recent Trades:

• Chief Medical Officer David Shapiro sold 2,000 shares of ICPT stock on 11/01/2018 at the average price of $96.32. The price of the stock has increased by 6.62% since.

For the complete insider trading history of ICPT, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 3 Warning Signs with ICPT. Click here to check it out.

• ICPT 15-Year Financial Data

• The intrinsic value of ICPT

• Peter Lynch Chart of ICPT